Ukraine: over 50% from COVID-19 Fund spent

As of October 23, UAH 34.1 billion, or 52%, has already been used from Ukraine’s COVID-19 Fund, the Finance Ministry’s press service reports. UAH 5.8 billion out of the planned UAH 16.3 billion or 35% was spent on healthcare. In particular, UAH 21 million was directed on the purchase of lung ventilation devices (UAH 100…



Kazakhstan: Atyrau region stockpiles pharmaceuticals for COVID-19 treatment sufficient for 3 months

The three-month stockpile of pharmaceuticals to treat the COVID-19 infection has been created in Atyrau region, Kazinform the press service of the press service of the region’s health office reports. 40 titles of the essential pharmaceuticals have been obtained through the social and business corporation Atyrau in order to ensure a stable supply of pharmaceuticals…

Kazakhstan: COVID-19 vaccine enters clinical trials

Clinical trials of Kazakhstani QazCovid-in vaccine against the COVID-19 virus developed by the Scientific Research Institute for Biological Safety Problems have started, the Ministry of Education and Science reports. Adult volunteers aged 18-50 years old will be involved in the clinical trials. Phase 1 trials will define the vaccine’s safety on 44 volunteers free of…

Ukraine: Farmak to gradually exit lockdown

Private joint-stock company Farmak (Kyiv), the pharmaceutical company, did not halt production and would gradually exit lockdown, the press service of the company reported. “Farmak continues production as usual. All lines are working as planned. However, after lockdown was announced all over the country on March 12 and the Health Ministry recommended that enterprises transfer…